Diabetes linked to lung cancer in postmenopausal women

May 30, 2012
Diabetes linked to lung cancer in postmenopausal women
Postmenopausal women with diabetes are at a significantly higher risk of developing lung cancer, particularly if they require insulin therapy, according to research published online May 22 in Diabetes Care.

(HealthDay) -- Postmenopausal women with diabetes are at a significantly higher risk of developing lung cancer, particularly if they require insulin therapy, according to research published online May 22 in Diabetes Care.

Juhua Luo, Ph.D., of West Virginia University in Morgantown, and colleagues utilized data from the Women's Health Initiative study involving a total of 145,765 postmenopausal women aged 50 to 79 years, of whom 8,154 had diabetes, who were followed for an average of 11 years. A total of 2,257 cases of were diagnosed.

The researchers found that postmenopausal women with self-reported treated diabetes were 27 percent more likely to be diagnosed with lung cancer compared with women without diabetes. Furthermore, postmenopausal women with diabetes who required were 71 percent more likely to be diagnosed with lung cancer. No association between lung cancer risk and either duration of diabetes or untreated diabetes was observed.

"In this large prospective study in , women with treated diabetes, especially those requiring insulin, had significantly higher risk of lung cancer," the authors write. "The risk of lung cancer did not differ significantly by duration of diabetes."

Explore further: Thiazolidinediones tied to lower cancer risk in diabetes patients

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Thiazolidinediones tied to lower cancer risk in diabetes patients

April 27, 2012
(HealthDay) -- Thiazolidinediones are associated with a lower risk of liver and colorectal cancer in patients with type 2 diabetes, according to a study published in the May issue of Hepatology.

Statin use in postmenopausal women associated with increased diabetes risk

January 9, 2012
The use of statins in postmenopausal women is associated with increased diabetes risk, according to a study published Online First by the Archives of Internal Medicine.

Lung cancer patients with diabetes show prolonged survival

October 17, 2011
Lung cancer patients with diabetes tend to live longer than patients without diabetes, according to a Norwegian study published in the November issue of the Journal of Thoracic Oncology, the official publication of the International ...

Recommended for you

Biochemical 'fingerprints' reveal diabetes progression

August 21, 2017
Researchers from Umeå University in Sweden describe a new method to study biochemical changes that occur in the pancreas during the development of diabetes. The method, recently published in Scientific Reports, is based ...

In a nutshell: Walnuts activate brain region involved in appetite control

August 17, 2017
Packed with nutrients linked to better health, walnuts are also thought to discourage overeating by promoting feelings of fullness. Now, in a new brain imaging study, researchers at Beth Israel Deaconess Medical Center (BIDMC) ...

Smart mat detects early warning signs of foot ulcers

August 16, 2017
While completing his residency in anesthesiology at Massachusetts General Hospital in the mid-2000s, Jon Bloom saw his fair share of foot amputations among patients with diabetes. The culprit: infected foot ulcers.

The best place to treat type 1 diabetes might be just under your skin

August 14, 2017
A group of U of T researchers have demonstrated that the space under our skin might be an optimal location to treat type 1 diabetes (T1D).

New measure of insulin-making cells could gauge diabetes progression, treatment

August 10, 2017
Researchers at the University of Wisconsin-Madison have developed a new measurement for the volume and activity of beta cells, the source of the sugar-regulating hormone insulin.

Pioneering immunotherapy shows promise in type 1 diabetes

August 9, 2017
It may be possible to 'retrain' the immune system to slow the progression of type 1 diabetes, according to results of a clinical trial published today in the journal Science Translational Medicine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.